Home / Generics

Generics

News

GSK appeals UK pay-for-delay fine posted 27/05/2016

GlaxoSmithKline (GSK) is appealing a GBP 37.6 million fine from the UK’s Competition and Markets Authority (CMA) over pay-for...

FDA approves first generic rosuvastatin posted 13/05/2016

The US Food and Drug Administration (FDA) announced on 29 April 2016 that it had approved the country’s first generic version...

Sun Pharma to buy 14 drug brands from Novartis in Japan posted 22/04/2016

A wholly owned subsidiary of India’s Sun Pharmaceutical Industries (Sun Pharma) will acquire a portfolio of 14 established pr...

Apotex launches generic of nasal allergy treatment posted 15/04/2016

On 24 March 2016, Canada-based Apotex announced that it had launched mometasone furoate monohydrate nasal spray in the US, th...

Teva launches generic acamprosate in US posted 08/04/2016

Israeli generics giant Teva Pharmaceutical Industries (Teva) announced on 22 March 2016 that it had launched a generic versio...

 

Research

Cost-effectiveness analysis and incentivizing innovation posted 27/05/2016

In the paper by Santiago Moreno and Joshua Ray, the controversial role that conventional cost-effectiveness analysis (CEA) pl...

Perceptions of the value of generics in Brazil posted 23/05/2016

Generics were first approved in Brazil in 1999. Substitution of generics and reference drugs can occur at the time of purchas...

Perceptions of the substitution of generics posted 20/05/2016

Pharmacists are mostly positive about the substitution of generics for brand-name drugs, according to a study analysing negat...

Perceptions of the safety and side effects of generics posted 20/05/2016

A quarter of doctors believe that generics are less safe and cause more side effects than brand-name drugs, according to a st...

Perceptions of the effectiveness and quality of generics posted 13/05/2016

More than a quarter of doctors and the general public believe that generics are less effective and of poorer quality than bra...

 

General

Australian generics maker opens clinical trials facility posted 20/05/2016

IDT Australia announced on 2 May 2016 that it had opened a new clinical trials facility in Adelaide.

Generics applications under review by EMA – April 2016 posted 20/05/2016

Generic medicines in Europe can be approved either centrally via the European Medicines Agency (EMA) or nationally via the lo...

FDA approves highest number of generics in 2015 posted 20/05/2016

The US Food and Drug Administration (FDA) approved more than 700 generics in 2015, more than in any previous year, according...

India’s bulk drug exports on the increase posted 03/05/2016

Driven by exports to both regulated and semi-regulated markets, India’s bulk drug exports are likely to grow at a compound an...

Lupin and Gavis to divest generics to appease US FTC posted 04/04/2016

Lupin Pharmaceuticals (Lupin) and Gavis Pharmaceuticals (Gavis) have reportedly agreed to sell two generics in order to final...

Generics News Research General

more

Biosimilars News Research General

more